Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$856M |
| 2 |
Meta Platforms (Facebook)
META
|
+$647M |
| 3 |
NVIDIA
NVDA
|
+$615M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$304M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.03B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$387M |
| 4 |
Abbott
ABT
|
+$380M |
| 5 |
Chevron
CVX
|
+$328M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.26% |
| 2 | Healthcare | 16.96% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Consumer Staples | 9.14% |
| 5 | Industrials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3601
Farmmi Inc
FAMI
$4.81M
| $54K | ﹤0.01% |
1,366
-90
| -6% | -$3.95K |
|
3602
Splash Beverage Group
SBEV
$2.58M
| $54K | ﹤0.01% |
+303
| New | +$55.4K |
|
|
AEY
3603
DELISTED
ADDvantage Technologies Group
AEY
| $54K | ﹤0.01% |
8,786
-1,764
| -17% | -$14.1K |
|
|
GLDG
3604
GoldMining Inc
GLDG
$223M
| $53K | ﹤0.01% |
+59,231
| New | +$60.9K |
|
3605
Matinas BioPharma
MTNB
$1.54M
| $53K | ﹤0.01% |
2,922
-517
| -15% | -$12.1K |
|
3606
SHF Holdings
SHFS
$1.14M
| $53K | ﹤0.01% |
+5,035
| New | +$51.1K |
|
3607
Xilio Therapeutics
XLO
$59.5M
| $53K | ﹤0.01% |
1,450
+107
| +8% | +$4.55K |
|
|
BLPH
3608
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
| $53K | ﹤0.01% |
77,299
-92,600
| -55% | -$596K |
|
3609
Lipocine
LPCN
$17M
| $52K | ﹤0.01% |
10,397
-1,271
| -11% | -$5.98K |
|
|
MLGO
3610
MicroAlgo
MLGO
$44.6M
| $52K | ﹤0.01% |
+4
| New | +$52.5K |
|
3611
Mega Matrix
MPU
$14.4M
| $52K | ﹤0.01% |
39,663
+16,163
| +69% | +$25.4K |
|
3612
Worksport
WKSP
$10.3M
| $52K | ﹤0.01% |
+2,150
| New | +$46.8K |
|
3613
IGC Pharma
IGC
$29.8M
| $51K | ﹤0.01% |
162,709
+52,409
| +48% | +$17K |
|
|
BNSO
3614
DELISTED
Bonso Electronic International
BNSO
| $51K | ﹤0.01% |
45,400
-79,706
| -64% | -$211K |
|
|
BEDU
3615
DELISTED
Bright Scholar Education Holdings
BEDU
| $50K | ﹤0.01% |
44,325
-7,530
| -15% | -$13.9K |
|
|
BRAG
3616
Bragg Gaming Group
BRAG
$55.2M
| $50K | ﹤0.01% |
+16,400
| New | +$54.4K |
|
3617
Prenetics Global
PRE
$318M
| $50K | ﹤0.01% |
3,720
+1,667
| +81% | +$21.8K |
|
|
EIGR
3618
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $50K | ﹤0.01% |
2,390
-13,199
| -85% | -$407K |
|
|
RIBT
3619
DELISTED
RiceBran Technologies
RIBT
| $50K | ﹤0.01% |
45,168
-800
| -2% | -$765 |
|
3620
Evogene
EVGN
$9.67M
| $49K | ﹤0.01% |
4,540
-7,279
| -62% | -$49.2K |
|
|
DGXX
3621
Digi Power X Inc
DGXX
$413M
| $49K | ﹤0.01% |
+27,100
| New | +$44K |
|
|
LFT
3622
Lument Finance Trust
LFT
$36.5M
| $48K | ﹤0.01% |
+25,497
| New | +$47.4K |
|
|
SGRP
3623
DELISTED
SPAR Group
SGRP
| $48K | ﹤0.01% |
38,200
-43,600
| -53% | -$52.6K |
|
3624
WidePoint Corp
WYY
$114M
| $48K | ﹤0.01% |
25,900
+5,400
| +26% | +$10K |
|
|
SCPX
3625
DELISTED
Scorpius Holdings, Inc.
SCPX
| $48K | ﹤0.01% |
18
+8
| +80% | +$22.9K |
|
Similar funds
Jim Simons's Q2 2023 Portfolio in Review
As of Q2 2023, Jim Simons held 4,468 positions worth $69.4B, down 7.9% from $75.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $8.1B in Q2 2023, closing 599 positions and reducing 1,691 holdings. Its most notable exit was UnitedHealth, an estimated $686M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Berkshire Hathaway Class A worth $316M.
- Jim Simons's largest Q2 2023 buy was Berkshire Hathaway Class A: 611 shares worth $316M.
- Jim Simons added most to Apple in Q2 2023, an estimated $856M increase.
- Jim Simons's biggest Q2 2023 reduction was Amazon, cutting an estimated $1.03B.
- Jim Simons fully exited UnitedHealth in Q2 2023, selling an estimated $686M.
- Jim Simons's ten largest holdings make up 12% of its $69.4B portfolio in Q2 2023.
- Jim Simons opened 541 new positions and closed 599 in Q2 2023.
- Jim Simons's portfolio value fell 7.9% quarter-over-quarter to $69.4B.
Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.